AI Contracts Tracker

Eli Lilly — Isomorphic Labs AI discovery collaboration (2024)

Isomorphic Labs will use AI for small-molecule discovery against multiple targets. Contingent milestones and royalties are separate from the upfront payment.

Enterprise Healthcare & life sciences

Verified

Announced
7 Jan 2024 1

Read the source Compare with related

Contract facts

Source per value
DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.
2024-01-071
BuyerThe purchasing organisation or named customer.
Eli Lilly and Company1
VendorThe contracting supplier or AI provider, as named in the source.
Isomorphic Labs1
SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.
Enterprise
Upfront payment $Upfront payment stated for research and licence collaborations.
$45,000,0001
Potential milestones $Contingent milestone payments stated for the collaboration, paid only if targets are reached.
$1,700,000,0001
ScopeThe use case or service scope named in the source.
Small molecule therapeutics discovery1

Sources

  1. storage.googleapis.com accessed 2026-11-11

Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.

Related contracts

All 87 contracts
  1. Undisclosed
  2. Undisclosed
  3. Undisclosed
  4. Undisclosed
  5. Undisclosed

Spot a change?

Amendment, renewal or a figure that moved? Email hello@aicontractstracker.com with the source link and we update this row and its verified date.